ECB sounds out lenders on exposure to Spanish drugmaker Grifols 

    Related

    Share


    Business & FinanceHealth

    Reuters exclusively reported that the European Central Bank was asking banks to detail their exposure to Spanish drugmaker Grifols and a network of companies linked to the founding family, days after the Barcelona-based business was accused of manipulating its financial accounts by a short-seller. The story also revealed how supervisors were concerned that the huge drop in Grifols’ share price could require family-connected companies which have borrowed using Grifols stock as collateral to post more margin. Grifols denies all the allegations made by Gotham City Research, the short-seller. The story was picked up by Bloomberg, Spain’s state-owned news agency, EFE, and made it into several newspapers including Expansion, El Mundo and the front page of business daily Cinco Dias. 

    Market Impact

    Since Jan. 9, the stock has lost nearly 40%. Gotham’s report has wiped more than 3.3 billion euros from Grifols’ market value.

    Article Tags

    Topics of Interest: Business & FinanceHealth

    Type: Reuters Best

    Sectors: Business & FinancePharmaceuticals & Healthcare

    Regions: Europe

    Countries: Spain

    Win Types: Exclusivity

    Story Types: Exclusive / Scoop

    Media Types: Text

    Customer Impact: Significant National Story



    Source link